Omeprazol Medinfar (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Medinfar, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and ulcer prevention in patients taking NSAIDs.

GNH USA supplies Omeprazol Medinfar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality manufacturing in accordance with EU standards and provides reliable global distribution.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by maintaining higher gastric pH. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence by reducing acid exposure. - NSAID‑induced ulcer prophylaxis: protects the gastric mucosa in patients receiving non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics and a bismuth compound.

Omeprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools. - Nausea: stomach upset. - Abdominal pain: discomfort in the abdomen.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or breathing difficulty. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps or irregular heartbeat. - Bone fractures: increased risk with prolonged therapy.

When prescribing omeprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for hepatitis C: prolonged use can increase risk of hepatic infection. - Monitor long‑term use: consider step‑down therapy after healing to avoid dependence. - Use with caution in pregnancy: only if benefit outweighs risk. - Review concomitant medications: potential interactions may require monitoring. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Digoxin: may increase serum levels. - Diazepam: enhanced sedation.